Table 1 Characteristics of the study subjects
From: Fibroblast growth factor-23 rs7955866 polymorphism and risk of chronic kidney disease
Parameter | CKD patients (N = 72) | Controls (N = 26) | Statistical test | P value |
|---|---|---|---|---|
Male | 35 (48.6%) | 14 (53.8%) | Chi-square | 0.647 |
Female | 37 (51.4%) | 12 (46.2%) | ||
Age (Y) | 48 (38.8–59.3) | 43 (36.5–52) | MWU | 0.179 |
S. Creatinine (mg/dL) | 1.5 (1.2–1.9) | 0.9 (0.7–1) | MWU | < 0.001** |
GFR-EPI (mL/min/1.73) | 44 (35.3–61.5) | 95.5 (81.3–112) | MWU | < 0.001** |
Proteinuria (gm/day) | 2.1 (1.2–4) | 0.1 (0.1–0.1) | MWU | < 0.001** |
S. Urea (mg/dL) | 81.44 ± 20.6 | 27.77 ± 5.9 | TT | < 0.001** |
S. Uric Acid (mg/dL) | 7.39 ± 2.4 | 5.08 ± 1.2 | TT | < 0.001** |
S. Proteins (gm/dL) | 6.4 (5.7–6.9) | 6.9 (6.4–7.1) | MWU | < 0.001** |
S. Albumin (gm/dL) | 3.2 (2.6–3.5) | 3.9 (3.7–4.1) | MWU | < 0.001** |
S. Calcium (mg/dL) | 9.09 ± 0.9 | 9.35 ± 0.6 | TT | 0.105 |
S. Phosphorus (mg/dL) | 4.88 ± 1 | 3.5 ± 0.3 | TT | < 0.001** |
S. iPTH (pg/mL) | 160.5 (100–202.5) | 41.5 (30–48) | MWU | < 0.001** |
S. Vitamin D3 (ng/mL) | 14.8 (12–22) | 35.2 (29.3–38.2) | MWU | < 0.001** |
S. iFGF23 (pg/mL) | 729.2 (531.9–972.3) | 126.1 (88.5–152.4) | MWU | < 0.001** |
Hemoglobin (gm/dL) | 10.2 (9.4–11.3) | 13.1 (12.9–14.3) | MWU | < 0.001** |
WBCs (k/uL) | 7.5 (5.9–9.3) | 5.9 (4–7.1) | MWU | < 0.001** |
Platelets (k/uL) | 296.63 ± 74.7 | 320.81 ± 39.8 | TT | 0.043* |